Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-09-19
2006-09-19
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S002600, C514S054000, C514S025000, C536S004100, C536S018500, C536S018600, C536S123100, C536S017100, C435S069100, C435S320100, C435S252100, C435S254100
Reexamination Certificate
active
07109182
ABSTRACT:
A pharmaceutical composition including a therapeutically effective amount of at least one oligomannoside produced by chemical synthesis which is homologous to a wall oligomannoside of an infectious organism or pathogen, or a derivative thereof, and a pharmaceutically acceptable vehicle.
REFERENCES:
patent: 4749566 (1988-06-01), Casellas et al.
patent: 4939123 (1990-07-01), Neeser et al.
patent: 57 054199 (1982-03-01), None
patent: 57 072996 (1982-05-01), None
patent: 57 072997 (1982-05-01), None
patent: 59 036690 (1984-02-01), None
patent: 59 036691 (1984-02-01), None
patent: 60 045587 (1985-03-01), None
patent: 60 045588 (1985-03-01), None
patent: 60 045589 (1985-03-01), None
Suzuki et al. “Immunichemical study on mammans of genus candida I. Structural investigation of antigenic factors 1,4,5,6,8,9,11,13,13b and 34.” Current Topics in Medical Mycology, vol. 8,No. 1-2,pp. 57-70, 1997.
Han et al. “a vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.” Infection and Immunity, vol. 66, No. 12, pp. 5771-5776, Dec. 1998.
Hideya Yuasa et al.,Synthesis of 5-Thiomannose-Containing Oligomannoside Mimics: Binding Abilities to Concanavalin A, Bioorganic & Medicinal Chemistry Letters, vol. 8, No. 11, Jun. 2, 1998, pp. 1297-1300.
Osamu Tsuruta et al.,Syntheses of Two Trimannose Analogs Each Containing C-Mannosyl or 5-Thio-C-Mannosyl Residue: Their Affinities to Concanavalin A, Bioorganic & Medicinal Chemistry Letters, vol. 9, No. 6, Mar. 22, 1999, pp. 807-810.
Hideya Yuasa et al.,Solid Phase Synthesis of Oligomannopeptoids That Mimic the concanavaline A-Binding Trimannoside, Bioorganic & Medicinal Chemistry Letters, vol. 8, No. 16, Aug. 18, 1998, pp. 2139-2144.
Pierre-André Trinel et al.,Mapping of Candida albicans Oligomannosidic Epitopes by Using Monoclonal Antibodies, Infection and Immunity, vol. 60, No. 9, Sep. 1992, pp. 3845-3851.
Yongmoon Han et al.,A Vaccine and Monoclonal Antibodies That Enhance Mouse Resistance to Candida albicans Vaginal Infection, Infection and Immunity, vol. 66, No. 12, Dec. 1998, pp. 5771-5776.
Mia Young et al.,Characterization of Oligosaccharides From an Antigenic Mannan of Saccharomyces cerevisiae, Glyocconjugate Journal, vol. 15, 1998, pp. 815-822.
Mason X. Zhang et al.,Contrasting Roles of Mannan-Specific Monoclonal Immunoglobulin M Antibodies in the Activation of Classical and Alternative Pathways by Candida albicans, Infection and Immunity, vol. 66, No. 12, Dec. 1998, pp. 6027-6029.
B. Sendid et al.,Specific Antibody Response to Oligomannosidic Epitopes in Crohn's Disease, Clinical and Diagnostic Laboratory Immunology, vol. 3, No. 2, Mar. 1996, pp. 219-226.
Pierre Marie Jacquinot et al.,Nature of Candida albicans-Derived Carbohydrate Antigen Recognized by a Monoclonal Antibody in Patient Sera and Distribution Over Candida Species, FEMS Microbiology Letters, vol. 169, Dec. 1, 1998, pp. 131-138.
Shigeo Suzuki,Immunochemical Study on Mannans of Genus Candida. I. Structural Investigation of Antigenic Factors 1, 4, 5, 6, 8, 9, 11, 13, 13b and 34, Current Topics in Medical Mycology, vol. 8, No. 1-2, 1997, pp. 57-70.
Chevalier Reynald
Colombel Jean-Frédéric
Esnault Jacques
Jouault Thierry
Mallet Jean-Maurice
Centre Hospitalier Regional Universitaire (CHRU)
Jiang Shaojia Anna
Khare Devesh
LandOfFree
Synthetic oligomannosides, preparation and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic oligomannosides, preparation and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic oligomannosides, preparation and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3584000